• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白作为稳定型缺血性心脏病的一种新型预后标志物:一项 3 年随访研究。

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.

机构信息

Attikon University General Hospital, 1 Rimini Str., 12462 Athens, Greece.

出版信息

Eur J Clin Invest. 2010 Apr;40(4):288-93. doi: 10.1111/j.1365-2362.2010.02257.x.

DOI:10.1111/j.1365-2362.2010.02257.x
PMID:20192976
Abstract

OBJECTIVES

Osteopontin (OPN) is a glycoprotein, which may play a major role in the regulation of biological phenomena. Increased levels of OPN have been linked to the presence and to the severity of atherosclerosis. This study was undertaken to assess the prognostic significance of plasma OPN levels in patients with stable ischaemic heart disease (IHD).

METHODS

In 101 patients with stable IHD and angiographically documented significant coronary artery stenosis, plasma OPN levels were measured at baseline (time of coronary arteriography). Patients were prospectively followed for a median time of 3 years (minimum 2.25, maximum 3.9 years). The primary study endpoint was the composite of cardiovascular death, non-fatal myocardial infarction, need for revascularization and hospitalization for cardiovascular reasons.

RESULTS

Baseline lnOPN levels were directly related to age (r = 0.27, P < 0.001) and inversely to left ventricular ejection fraction (r = -0.32, P < 0.01). Left ventricular ejection fraction was an independent predictor of plasma OPN levels after adjustment for age and gender (beta = -0.013, P = 0.02). Median OPN value was 55 ng mL(-1). In the univariate Cox-regression analysis, OPN levels > 55 ng mL(-1) (n = 50) were significantly related to adverse cardiac outcome (HR = 2.40, 95% CI: 1.11-5.23, P = 0.027). In multivariate model, OPN levels > 55 ng mL(-1) remained statistically significant independent predictor of adverse outcome after adjustment for age, gender, left ventricular ejection fraction and the number of diseased coronary arteries (HR = 2.88, 95% CI: 1.09-7.58, P = 0.032).

CONCLUSION

OPN may provide significant prognostic information independent of other traditional prognostic markers in patients with stable IHD.

摘要

目的

骨桥蛋白(OPN)是一种糖蛋白,可能在调节生物现象中发挥主要作用。OPN 水平升高与动脉粥样硬化的存在和严重程度有关。本研究旨在评估稳定型缺血性心脏病(IHD)患者血浆 OPN 水平的预后意义。

方法

在 101 例经冠状动脉造影证实有严重冠状动脉狭窄的稳定型 IHD 患者中,在基线时(冠状动脉造影时)测量血浆 OPN 水平。前瞻性随访患者中位时间为 3 年(最短 2.25 年,最长 3.9 年)。主要研究终点是心血管死亡、非致死性心肌梗死、血运重建和因心血管原因住院的复合终点。

结果

基线 lnOPN 水平与年龄呈直接相关(r = 0.27,P < 0.001),与左室射血分数呈负相关(r = -0.32,P < 0.01)。在校正年龄和性别后,左室射血分数是血浆 OPN 水平的独立预测因子(β = -0.013,P = 0.02)。中位数 OPN 值为 55ng/ml。在单变量 Cox 回归分析中,OPN 水平>55ng/ml(n = 50)与不良心脏结局显著相关(HR = 2.40,95%CI:1.11-5.23,P = 0.027)。在多变量模型中,校正年龄、性别、左室射血分数和病变冠状动脉数量后,OPN 水平>55ng/ml 仍然是不良结局的独立预测因子(HR = 2.88,95%CI:1.09-7.58,P = 0.032)。

结论

OPN 可能为稳定型 IHD 患者提供独立于其他传统预后标志物的重要预后信息。

相似文献

1
Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.骨桥蛋白作为稳定型缺血性心脏病的一种新型预后标志物:一项 3 年随访研究。
Eur J Clin Invest. 2010 Apr;40(4):288-93. doi: 10.1111/j.1365-2362.2010.02257.x.
2
Prognostic significance of plasma osteopontin levels in patients with chronic stable angina.慢性稳定型心绞痛患者血浆骨桥蛋白水平的预后意义
Eur Heart J. 2006 Apr;27(7):802-7. doi: 10.1093/eurheartj/ehi730. Epub 2006 Jan 18.
3
Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris.血清新蝶呤水平升高可预测慢性稳定型心绞痛患者未来的不良心脏事件。
Eur Heart J. 2005 Mar;26(5):457-63. doi: 10.1093/eurheartj/ehi111. Epub 2005 Jan 31.
4
Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.血浆基质金属蛋白酶-3水平是稳定型冠状动脉疾病的独立预后因素。
Eur J Clin Invest. 2005 Sep;35(9):537-45. doi: 10.1111/j.1365-2362.2005.01548.x.
5
B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.B型利钠肽与稳定型心绞痛患者心血管事件及死亡风险:动脉粥样硬化基因研究结果
J Am Coll Cardiol. 2006 Feb 7;47(3):552-8. doi: 10.1016/j.jacc.2005.09.039. Epub 2006 Jan 18.
6
Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.在慢性肾脏病患者中,骨桥蛋白的循环水平与肾小球滤过率和心血管风险标志物密切相关。
Eur J Clin Invest. 2010 Apr;40(4):294-300. doi: 10.1111/j.1365-2362.2010.02271.x.
7
Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.骨桥蛋白在乙型肝炎病毒相关肝细胞癌中的预后意义
Dig Liver Dis. 2007 Feb;39(2):167-72. doi: 10.1016/j.dld.2006.10.015. Epub 2006 Dec 11.
8
Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.接受放化疗的头颈癌患者的血浆骨桥蛋白水平
Arch Otolaryngol Head Neck Surg. 2009 Aug;135(8):807-11. doi: 10.1001/archoto.2009.103.
9
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.C反应蛋白和纤维蛋白原对稳定型心绞痛患者心血管预后的影响:动脉粥样基因研究
Eur Heart J. 2006 Dec;27(24):2962-8. doi: 10.1093/eurheartj/ehl362. Epub 2006 Nov 28.
10
Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris.慢性稳定型心绞痛患者妊娠相关血浆蛋白-A水平、临床特征与冠状动脉疾病程度之间的关系。
Eur Heart J. 2005 Oct;26(20):2093-8. doi: 10.1093/eurheartj/ehi433. Epub 2005 Jul 29.

引用本文的文献

1
Single-cell and bulk RNA sequencing reveals specific Trem2 positive B cell subtype niche after myocardial infarction in mice.单细胞和批量RNA测序揭示了小鼠心肌梗死后特定的Trem2阳性B细胞亚群生态位。
Mamm Genome. 2025 Jun 16. doi: 10.1007/s00335-025-10144-w.
2
Osteopontin as a Biomarker for Coronary Artery Disease.骨桥蛋白作为冠状动脉疾病的生物标志物
Cells. 2025 Jan 13;14(2):106. doi: 10.3390/cells14020106.
3
Expression of Osteopontin and Gremlin 1 Proteins in Cardiomyocytes in Ischemic Heart Failure.骨桥蛋白和 Gremlin 1 蛋白在缺血性心力衰竭心肌细胞中的表达。
Int J Mol Sci. 2024 Jul 28;25(15):8240. doi: 10.3390/ijms25158240.
4
Integrative bioinformatics approach for identifying key genes and potential therapeutic targets in the concurrent manifestation of hypertrophic cardiomyopathy and pulmonary hypertension.用于识别肥厚型心肌病与肺动脉高压并发表现中关键基因和潜在治疗靶点的整合生物信息学方法
J Thorac Dis. 2024 May 31;16(5):3152-3169. doi: 10.21037/jtd-23-1822. Epub 2024 May 28.
5
Serum secreted phosphoprotein 1 level is associated with plaque vulnerability in patients with coronary artery disease.血清分泌磷蛋白 1 水平与冠心病患者斑块易损性相关。
Front Immunol. 2024 Feb 15;15:1285813. doi: 10.3389/fimmu.2024.1285813. eCollection 2024.
6
The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)-A Narrative Review.骨桥蛋白在动脉粥样硬化及其临床表现(动脉粥样硬化性心血管疾病)中的作用——一项叙述性综述
Biomedicines. 2023 Nov 29;11(12):3178. doi: 10.3390/biomedicines11123178.
7
Osteopontin Activation and Microcalcification in Venous Grafts Can Be Modulated by Dexamethasone.地塞米松可调节静脉移植物中的骨桥蛋白激活和微钙化。
Cells. 2023 Nov 15;12(22):2627. doi: 10.3390/cells12222627.
8
Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease.血清骨桥蛋白和护骨素水平与外周动脉疾病血管内再通后不良结局的关系。
Cardiovasc Diabetol. 2022 Sep 1;21(1):171. doi: 10.1186/s12933-022-01605-6.
9
Osteopontin in Cardiovascular Diseases.骨桥蛋白在心血管疾病中的作用
Biomolecules. 2021 Jul 16;11(7):1047. doi: 10.3390/biom11071047.
10
Relationship Between Plasma Osteopontin and Arginine Pathway Metabolites in Patients With Overt Coronary Artery Disease.显性冠状动脉疾病患者血浆骨桥蛋白与精氨酸途径代谢物之间的关系
Front Physiol. 2020 Aug 6;11:982. doi: 10.3389/fphys.2020.00982. eCollection 2020.